SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-006025
Filing Date
2020-03-24
Accepted
2020-03-24 16:41:03
Documents
3
Period of Report
2020-03-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20200323_8k.htm 8-K 20281
2 EXHIBIT 99.1 ex_178686.htm EX-99.1 11475
3 logo.jpg GRAPHIC 8653
  Complete submission text file 0001437749-20-006025.txt   45192
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 20738900
SIC: 2834 Pharmaceutical Preparations